莱美药业前三季度净利亏损4591.72万元

Core Insights - The company reported a revenue of 581 million yuan for the first three quarters of 2025, representing a year-on-year decline of 4.06% [1] - The net profit attributable to shareholders for the same period was -45.92 million yuan [1] - In the third quarter, the company achieved a revenue of 204 million yuan, which is a year-on-year decrease of 8.95% [1] - The net profit attributable to shareholders in the third quarter was -14.54 million yuan [1]